Shanghai - Delayed Quote CNY
Qingdao Haier Biomedical Co.,Ltd (688139.SS)
31.34
+0.21
+(0.67%)
At close: May 23 at 3:00:03 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
251,681.12
291,666.92
249,264.53
632,429.33
591,798.01
Operating Cash Flow
--
291,666.92
249,264.53
632,429.33
591,798.01
Investing Cash Flow
-701,252.77
-791,216.71
252,756.08
-251,174.69
-1,501,417
Financing Cash Flow
-224,499.82
-226,827.27
-168,299.49
-206,234.32
-136,012.86
End Cash Position
633,000.25
534,704.03
1,256,646.56
931,163.71
747,244.87
Capital Expenditure
-114,194.77
-126,704.81
-177,181.49
-294,244.91
-204,685.72
Issuance of Debt
20,000
10,000
6,000
--
--
Repayment of Debt
--
-18,588.21
-22,500
-5,000
-25,000
Free Cash Flow
137,486.36
164,962.11
72,083.05
338,184.42
387,112.29
12/31/2021 - 10/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade